Latest Drugs, Latest Approval in Group III antiarrhythmics

What are Group III antiarrhythmics?

Group III antiarrhythmics: Potassium-channel blockers, bind to and block the potassium channels which prolongs repolarization of the cell membrane.

Name	Updated
Sotalol (Sotalol)	18-Oct-2023
Nexterone (Amiodarone (injection) [ a-mi-oh-da-rone ])	02-Oct-2023
Amiodarone (injection) (Amiodarone (injection) [ a-mi-oh-da-rone ])	16-Aug-2023
Dronedarone (Dronedarone [ droe-ne-da-rone ])	15-Aug-2023
Dofetilide (Dofetilide [ doe-fet-i-lide ])	14-Aug-2023
Ibutilide (Ibutilide [ eye-bue-til-ide ])	13-Aug-2023
Sotalol (Sotalol (oral/injection) [ soe-ta-lol ])	12-Aug-2023
Tikosyn (Dofetilide)	14-Jul-2023
Pacerone (Amiodarone (oral) [ a-mi-oh-da-rone ])	13-Jul-2023
Nexterone (Amiodarone (injection) [ a-mi-oh-da-rone ])	13-Jul-2023
Multaq (Dronedarone [ droe-ne-da-rone ])	13-Jul-2023
Corvert (Ibutilide [ eye-bue-til-ide ])	13-Jul-2023
Betapace (Sotalol hydrochloride)	12-Jul-2023
Amiodarone (Amiodarone tablets (oral) [ a-mi-oh-da-rone ])	10-Jul-2023